RECURRENT CERVICAL CANCER
Clinical trials for RECURRENT CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CERVICAL CANCER trials appear
Sign up with your email to follow new studies for RECURRENT CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for women with returning cervical cancer
Disease control CompletedThis study tested a new treatment combination for women whose cervical cancer has returned after standard chemotherapy. It combined an immunotherapy drug (anti-PD-1) with a chemotherapy drug (albumin-bound paclitaxel) to see if it could shrink tumors and control the disease. The …
Matched conditions: RECURRENT CERVICAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug trial offers hope for women with advanced cervical cancer
Disease control CompletedThis study tested whether the chemotherapy drug eribulin could help control advanced or recurrent cervical cancer. Thirty-two women with cervical cancer that had spread or returned after treatment received eribulin infusions every three weeks. Researchers measured how long the ca…
Matched conditions: RECURRENT CERVICAL CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 18, 2026 14:55 UTC